➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Medtronic
McKinsey
Baxter
Dow

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

METAPROTERENOL SULFATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Metaproterenol Sulfate, and what generic alternatives are available?

Metaproterenol Sulfate is a drug marketed by Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Cosette, G And W Labs Inc, Lannett Co Inc, Morton Grove, Am Therap, Heritage Pharma, Par Pharm, Usl Pharma, and Watson Labs. and is included in twenty-nine NDAs.

The generic ingredient in METAPROTERENOL SULFATE is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Metaproterenol Sulfate

A generic version of METAPROTERENOL SULFATE was approved as metaproterenol sulfate by LANNETT CO INC on July 22nd, 1992.

  Get Started for $10

Drug patent expirations by year for METAPROTERENOL SULFATE
Pharmacology for METAPROTERENOL SULFATE
Medical Subject Heading (MeSH) Categories for METAPROTERENOL SULFATE

US Patents and Regulatory Information for METAPROTERENOL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 071014-001 Jan 25, 1988 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Watson Labs METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 073013-001 Jan 31, 1991 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Apotex Inc METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 075402-001 Feb 28, 2001 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Lannett Co Inc METAPROTERENOL SULFATE metaproterenol sulfate SYRUP;ORAL 073632-001 Jul 22, 1992 RX No Yes   Get Started for $10   Get Started for $10   Get Started for $10
Heritage Pharma METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 072520-001 Mar 30, 1990 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Dey METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 070805-001 Aug 17, 1987 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Moodys
Johnson and Johnson
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.